Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer-associated venous thromboembolism.

Benjamin SimmonsWaldemar E WysokinskiRayya A SaadiqDalene Bott-KitslaarStanislav HenkinAna CasanegraCharles LenzPaul DanielsHaraldur BjarnasonEmily VargasDavid HodgeSara J HoltonJames R CerhanCharles LoprinziRobert D McBane Ii

Published in: European journal of haematology (2018)

The results of this "real-world" experience with cVTE suggest that rivaroxaban may offer a safe and effective alternative to LMWH.

Keyphrases

venous thromboembolism
direct oral anticoagulants
atrial fibrillation